
Indrayani Biotech Ltd Upgraded to Hold on Improving Financials and Valuation
2026-11-17 08:09:31Indrayani Biotech Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Sell to Hold as of 16 Nov 2026. This change reflects a nuanced improvement across key parameters including quality, valuation, financial trends, and technical indicators, signalling a cautious but positive outlook for investors.
Read More
Indrayani Biotech Ltd is Rated Sell
2026-10-21 10:10:56Indrayani Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Indrayani Biotech Ltd is Rated Sell by MarketsMOJO
2026-10-09 10:10:40Indrayani Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Indrayani Biotech Ltd Reports Positive Financial Trend Amidst Market Challenges
2026-10-09 08:00:07Indrayani Biotech Ltd, a micro-cap player in the Other Agricultural Products sector, has demonstrated a notable improvement in its financial performance for the quarter ended June 2026. After a period of stagnation, the company’s financial trend has shifted from flat to positive, driven by robust revenue growth and a significant rise in profit after tax (PAT), signalling a potential turnaround despite lingering concerns over non-operating income contributions.
Read More
Indrayani Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-09-28 08:03:30Indrayani Biotech Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Strong Sell to Sell as of 25 September 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges, prompting a reassessment of its near-term prospects by market analysts.
Read More
Indrayani Biotech Ltd is Rated Strong Sell
2026-09-17 10:11:20Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Indrayani Biotech Ltd is Rated Strong Sell
2026-09-04 10:11:07Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 September 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
10-Nov-2026 | Source : BSEIntimation of News Paper publication for the matters relating to Rights Issue.
Reg. 34 (1) Annual Report.
07-Nov-2026 | Source : BSEAnnual Report of the Company for the Financial year ended March 31 2026.
Receipt Of Listing Approval
06-Nov-2026 | Source : BSECompany has received on Listing Approval from BSE for the Proposed Rights issue.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Indrayani Biotech Ltd has announced 5:7 rights issue, ex-date: 28 Apr 26